FLT3 Internal Tandem Duplication Measurable Residual Disease in Complete Remission Identifies Patients with AML with Profound Risk for Relapse and Death
Impact of NGS-based detection of FLT3 internal tandem duplication measurable residual disease on treatment outcome in newly diagnosed acute myeloid leukaemia